Protective gene mutation gives hope to Alzheimer’s drug development
By
McKnight's Staff
Jul 16, 2012
Alzheimer’s researchers got a huge boost last week with the publication of a study showing that a rare genetic mutation prevents the buildup of beta amyloid in the brain.
Experimental Alzheimer’s drug fails to deliver in closely watched clinical trial
By
McKnight's Staff
Jul 25, 2012
Alzheimer’s researchers met with disappointment Monday when officials from Pfizer announced that the experimental drug bapineuzumab failed to improve dementia symptoms in a Phase 3 trial.
Alzheimer’s origin story is about metabolism and lifestyle, scientists contend
By
Alicia Lasek
Apr 02, 2021
Alzheimer’s Disease is increasingly being referred to as insulin resistance of the brain, or Type 3 diabetes, a research team says.